0001209191-15-079096.txt : 20151110 0001209191-15-079096.hdr.sgml : 20151110 20151109162241 ACCESSION NUMBER: 0001209191-15-079096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151105 FILED AS OF DATE: 20151109 DATE AS OF CHANGE: 20151109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frenkel Ran CENTRAL INDEX KEY: 0001623108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 151215923 MAIL ADDRESS: STREET 1: KARYOPHARM THERAPEUTICS, INC. STREET 2: 85 WELLS AVENUE, 2ND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-05 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001623108 Frenkel Ran C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 0 1 0 0 EVP, WW Development Operations Restricted Stock Units 2015-11-05 4 A 0 30000 0.00 A Common Stock 30000 30000 D Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. 50% of the restricted stock units will vest on November 5, 2016, and the remaining 50% of the restricted stock units will vest on November 5, 2017. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date. /s/ Christopher B. Primiano as Attorney-in-Fact for Ran Frenkel 2015-11-09